A single director's Form 144 for ~$4.4M is a routine liquidity event, especially when the shares were just acquired via option exercise. The sale is not part of a broader insider cluster. Monitor for any follow-on Form 4 filings to confirm execution, but no immediate trading signal is warranted.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 19 $608.27entry
- T+1 · 3mo ago +0.72%α +1.56% · $612.64
- T+5 · 3mo ago +1.77%α +2.16% · $619.05
- T+20 · 2mo ago +1.14%α +3.09% · $615.18
- T+60 · 5d ago +7.98%α +9.54% · $656.84
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director Fred B. Davenport Jr. filed a Form 144 on August 19, 2026, indicating intent to sell 7,283 shares of Medpace Holdings common stock, with an estimated aggregate market value of approximately $4.4 million. The shares were acquired via a stock option exercise on the same date, and the sale is to be executed through Fidelity Brokerage Services. This is a single filing by a director, not a cluster of multiple insiders, and the dollar amount is modest relative to the company's $16.5B market cap.
Key Facts
- Reporting owner: Fred B. Davenport Jr., a Director of Medpace Holdings, Inc.
- Securities to be sold: 7,283 shares of Common Stock
- Estimated aggregate market value of shares to be sold: $4,414,616.10
- Shares acquired via stock option exercise on August 19, 2026 (same day as filing)
- Broker: Fidelity Brokerage Services LLC
- Filing date: August 19, 2026
Financial Impact
Director intends to sell ~$4.4M worth of MEDP common stock, representing a small fraction of the company's $16.5B market cap.
Risk Factors
- Insider selling could be perceived negatively by the market if it precedes a negative catalyst, though no such catalyst is indicated here.
- The sale may not occur; Form 144 is an intent to sell, not a completed transaction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (MEDP), Batch item 1 | 0001959173-26-006223 |
| Document: 0001959173-26-006223-index.html | 0001959173-26-006223 |
| Document: 0001959173-26-006223.txt | 0001959173-26-006223 |
| 144 Filing (MEDP), Batch item 4 | 0001959173-26-006223 |
| Document: 0001959173-26-006223-index.html | 0001959173-26-006223 |
| Document: 0001959173-26-006223.txt | 0001959173-26-006223 |
Track record
24 reports on MEDP
5 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +11.09% at T+20 after the Dec 4, 2025 report. 5 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $652.28 Now $648.20 +0.62% settles Nov 17
- Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $653.94 to $648.20 Now $648.20 −0.88% ▼ −0.88% +1.03% vs SPY
- Nov 2, 202614d ago Insider Cluster Bearish 4/10 Entry $663.49 to $656.77 Now $648.20 +2.30% ▲ +1.01% +2.66% vs SPY
- Oct 29, 202618d ago 144 Neutral 2/10 Entry $677.56 to $652.01 Now $648.20 −4.33% ▼ −3.77% −2.00% vs SPY
- Oct 27, 202620d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
- Oct 26, 202621d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $669.20 to $676.77 Now $648.20 −3.14% ▲ +1.13% +0.42% vs SPY
- Oct 21, 202626d ago 8-K Bullish 6/10 Entry $653.96 to $669.20 Now $648.20 −0.88% ▲ +2.33% +2.85% vs SPY
- Sep 28, 20267w ago SC 13D/A Neutral 4/10 Entry $622.11 to $624.18 Now $648.20 +4.19% ▲ +0.33% +0.54% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $583.21 to $593.02 Now $648.20 +11.14% ▲ +1.68% +1.24% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers